Kishimoto, T., Kojima, Y., & Fujimoto, N. (2021). Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion. Nature Portfolio.
Chicago Style (17th ed.) CitationKishimoto, Takumi, Yoko Kojima, and Nobukazu Fujimoto. Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion. Nature Portfolio, 2021.
MLA (8th ed.) CitationKishimoto, Takumi, et al. Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.